Logo image of ALECP.PA

EUROPACORP (ALECP.PA) Stock Fundamental Analysis

EPA:ALECP - Euronext Paris - Matif - FR0010490920 - Common Stock - Currency: EUR

0.456  -0.01 (-1.72%)

Fundamental Rating

3

Overall ALECP gets a fundamental rating of 3 out of 10. We evaluated ALECP against 46 industry peers in the Entertainment industry. ALECP has a medium profitability rating, but doesn't score so well on its financial health evaluation. ALECP has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

ALECP had positive earnings in the past year.
ALECP had a positive operating cash flow in the past year.
ALECP had positive earnings in 4 of the past 5 years.
ALECP had a positive operating cash flow in each of the past 5 years.
ALECP.PA Yearly Net Income VS EBIT VS OCF VS FCFALECP.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M -100M

1.2 Ratios

Looking at the Return On Assets, with a value of 0.84%, ALECP is in line with its industry, outperforming 56.52% of the companies in the same industry.
ALECP has a better Return On Invested Capital (1.11%) than 60.87% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for ALECP is below the industry average of 8.60%.
The last Return On Invested Capital (1.11%) for ALECP is well below the 3 year average (5.62%), which needs to be investigated, but indicates that ALECP had better years and this may not be a problem.
Industry RankSector Rank
ROA 0.84%
ROE N/A
ROIC 1.11%
ROA(3y)4.53%
ROA(5y)10.29%
ROE(3y)6392.79%
ROE(5y)N/A
ROIC(3y)5.62%
ROIC(5y)N/A
ALECP.PA Yearly ROA, ROE, ROICALECP.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5K 10K 15K

1.3 Margins

ALECP has a Profit Margin (2.43%) which is in line with its industry peers.
In the last couple of years the Profit Margin of ALECP has declined.
The Operating Margin of ALECP (3.22%) is comparable to the rest of the industry.
In the last couple of years the Operating Margin of ALECP has declined.
Looking at the Gross Margin, with a value of 35.15%, ALECP is doing worse than 69.57% of the companies in the same industry.
In the last couple of years the Gross Margin of ALECP has grown nicely.
Industry RankSector Rank
OM 3.22%
PM (TTM) 2.43%
GM 35.15%
OM growth 3Y-15.27%
OM growth 5YN/A
PM growth 3Y-79.82%
PM growth 5YN/A
GM growth 3Y-8.27%
GM growth 5Y13.87%
ALECP.PA Yearly Profit, Operating, Gross MarginsALECP.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100 200

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so ALECP is still creating some value.
ALECP has about the same amout of shares outstanding than it did 1 year ago.
Compared to 5 years ago, ALECP has more shares outstanding
Compared to 1 year ago, ALECP has an improved debt to assets ratio.
ALECP.PA Yearly Shares OutstandingALECP.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
ALECP.PA Yearly Total Debt VS Total AssetsALECP.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

Based on the Altman-Z score of -1.65, we must say that ALECP is in the distress zone and has some risk of bankruptcy.
ALECP's Altman-Z score of -1.65 is on the low side compared to the rest of the industry. ALECP is outperformed by 82.61% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -1.65
ROIC/WACC0.27
WACC4.17%
ALECP.PA Yearly LT Debt VS Equity VS FCFALECP.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M

2.3 Liquidity

ALECP has a Current Ratio of 1.34. This is a normal value and indicates that ALECP is financially healthy and should not expect problems in meeting its short term obligations.
ALECP has a Current ratio of 1.34. This is in the better half of the industry: ALECP outperforms 76.09% of its industry peers.
ALECP has a Quick Ratio of 1.34. This is a normal value and indicates that ALECP is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.34, ALECP is in the better half of the industry, outperforming 76.09% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.34
Quick Ratio 1.34
ALECP.PA Yearly Current Assets VS Current LiabilitesALECP.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

2

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 1260.00% over the past year.
The earnings per share for ALECP have been decreasing by -82.55% on average. This is quite bad
The Revenue has decreased by -5.77% in the past year.
ALECP shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -24.98% yearly.
EPS 1Y (TTM)1260%
EPS 3Y-82.55%
EPS 5YN/A
EPS Q2Q%-8120%
Revenue 1Y (TTM)-5.77%
Revenue growth 3Y-5.23%
Revenue growth 5Y-24.98%
Sales Q2Q%-14.72%

3.2 Future

Based on estimates for the next years, ALECP will show a very negative growth in Earnings Per Share. The EPS will decrease by -29.00% on average per year.
The Revenue is expected to decrease by -46.64% on average over the next years. This is quite bad
EPS Next Y-0.92%
EPS Next 2Y-29%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-39.23%
Revenue Next 2Y-46.64%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ALECP.PA Yearly Revenue VS EstimatesALECP.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 100M 200M 300M 400M 500M
ALECP.PA Yearly EPS VS EstimatesALECP.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 0.5 -0.5 -1 -1.5 -2

4

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 45.60, the valuation of ALECP can be described as expensive.
Compared to the rest of the industry, the Price/Earnings ratio of ALECP indicates a somewhat cheap valuation: ALECP is cheaper than 65.22% of the companies listed in the same industry.
ALECP is valuated expensively when we compare the Price/Earnings ratio to 29.35, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 7.32, which indicates a rather cheap valuation of ALECP.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ALECP indicates a rather cheap valuation: ALECP is cheaper than 91.30% of the companies listed in the same industry.
ALECP is valuated cheaply when we compare the Price/Forward Earnings ratio to 22.10, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 45.6
Fwd PE 7.32
ALECP.PA Price Earnings VS Forward Price EarningsALECP.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ALECP indicates a somewhat cheap valuation: ALECP is cheaper than 67.39% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 4.64
ALECP.PA Per share dataALECP.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2

4.3 Compensation for Growth

ALECP's earnings are expected to decrease with -29.00% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-29%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for ALECP!.
Industry RankSector Rank
Dividend Yield N/A

EUROPACORP

EPA:ALECP (3/7/2025, 7:00:00 PM)

0.456

-0.01 (-1.72%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)12-12 2024-12-12
Earnings (Next)05-27 2025-05-27
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners13.1%
Ins Owner ChangeN/A
Market Cap57.19M
Analysts86.67
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 45.6
Fwd PE 7.32
P/S 1.62
P/FCF N/A
P/OCF 2.52
P/B N/A
P/tB N/A
EV/EBITDA 4.64
EPS(TTM)0.01
EY2.19%
EPS(NY)0.06
Fwd EY13.67%
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)0.18
OCFY39.62%
SpS0.28
BVpS-0.02
TBVpS-0.33
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.84%
ROE N/A
ROCE 1.88%
ROIC 1.11%
ROICexc 2.7%
ROICexgc N/A
OM 3.22%
PM (TTM) 2.43%
GM 35.15%
FCFM N/A
ROA(3y)4.53%
ROA(5y)10.29%
ROE(3y)6392.79%
ROE(5y)N/A
ROIC(3y)5.62%
ROIC(5y)N/A
ROICexc(3y)18.2%
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)9.48%
ROCE(5y)5.63%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3Y-18.69%
ROICexc growth 5YN/A
OM growth 3Y-15.27%
OM growth 5YN/A
PM growth 3Y-79.82%
PM growth 5YN/A
GM growth 3Y-8.27%
GM growth 5Y13.87%
F-Score6
Asset Turnover0.34
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA 2.87
Cap/Depr 126.09%
Cap/Sales 66.38%
Interest Coverage 0.75
Cash Conversion 114.82%
Profit Quality N/A
Current Ratio 1.34
Quick Ratio 1.34
Altman-Z -1.65
F-Score6
WACC4.17%
ROIC/WACC0.27
Cap/Depr(3y)71.16%
Cap/Depr(5y)N/A
Cap/Sales(3y)33%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)1260%
EPS 3Y-82.55%
EPS 5YN/A
EPS Q2Q%-8120%
EPS Next Y-0.92%
EPS Next 2Y-29%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-5.77%
Revenue growth 3Y-5.23%
Revenue growth 5Y-24.98%
Sales Q2Q%-14.72%
Revenue Next Year-39.23%
Revenue Next 2Y-46.64%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-72.69%
EBIT growth 3Y-19.7%
EBIT growth 5YN/A
EBIT Next Year149.11%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-105.22%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y26.59%
OCF growth 3Y85.22%
OCF growth 5Y-28.94%